Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia
✍ Scribed by Kropshofer, Gabriele ;Wehl, G. ;Högler, W. ;Meister, B. ;Heitger, A. ;Nussbaumer, W.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 33 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The objective of this study was to investigate the efficacy and safety of alemtuzumab, the humanized anti‐CD52 monoclonal antibody, in patients with B‐cell chronic lymphocytic leukemia and residual disease after chemotherapy. ## METHODS Forty‐one patients received alemt
hospital with signs of acute intracranial pressure. The MRIscan showed massive brain edema around the catheter shaft (Fig. 2). Thus, it was clear that even though we had been always able to aspirate cerebrospinal fluid, we obviously had instilled methotrexate directly into the parenchyma. This resul